Join us in welcoming Peter Marks, M.D., Ph.D. as he discusses the advances in regenerative medicine clinical trials, FDA programs to accelerate the evaluation of regenerative medicine therapies and more. Dr. Marks is the director of FDA Center for Biologics Evaluation and Research (CBER). For more information or the register, view the event flyer below.
